MicroStrategy's rebranding highlights its BTC focus and innovative financing, positioning it for growth amid evolving BTC ...
The results suggest the potential of semaglutide – the main ingredient in Ozempic and Novo’s higher-dose weight-loss drug ...
In a recent filing with the Securities and Exchange Commission, Zions Bancorporation, National Association (NASDAQ:ZION), an $8.2 billion market cap bank trading at a P/E ratio of 11.15, disclosed ...
MOBILE, Ala. - TruBridge, Inc. (NASDAQ: TBRG), a provider of healthcare technology solutions, has been selected as a preferred partner by Cibolo Health, a company specializing in the financial ...
The government has been urged to take action to stop and reverse the proliferation of small pension pots, after a report from the Institute for Fiscal Studies (IFS) suggested that there is a strong ca ...
These seven equal weight ETFs offer a more balanced approach to superior performance.
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
Bleakley Financial Group LLC trimmed its position in shares of Fortive Co. (NYSE:FTV – Free Report) by 3.4% in the 4th ...
The top U.S. securities regulator revised guidance on Wednesday to make it easier for companies to avoid bringing shareholder ...
(Reuters) - Albemarle, the world's largest producer of lithium, said on Wednesday it swung to a quarterly profit as cost cuts ...
JPMorgan analyst Richard Sunderland assumed coverage of PG&E with an Overweight rating and $22 price target With the shares having ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results